Literature DB >> 20596750

Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image.

Ryota Mashiko1, Shingo Takano, Eiichi Ishikawa, Tetsuya Yamamoto, Kei Nakai, Akira Matsumura.   

Abstract

Hypoxia-inducible factor (HIF)-1α and HIF-2α expression were investigated immunohistochemically as determinants of prognosis in 42 cases of astrocytic tumors associated with necrosis grade on magnetic resonance (MR) imaging. Expression of HIF-1α was determined immunohistologically. The degree of necrosis on MR images was divided into four grades. Kaplan-Meier analysis revealed a significant effect of necrosis grade on MR images on cumulative overall survival. Median survival times were 26, 14, and 13 months for patients with necrosis grades 1, 2, and 3, respectively (not defined for grade 0). Kaplan-Meier analysis revealed a significant effect of HIF-1α expression on cumulative overall survival. Median survival time of patients with HIF-1α expression was 17 months, whereas it was 80 months for patients without HIF-1α expression. However, overexpression of HIF-2α did not correlate with malignant features, for example angiogenesis or necrosis, and had no impact on overall survival of patients with glial tumors. In conclusion, HIF-1α, but not HIF-2α, is a useful prognostic factor in astrocytic tumor associated with necrosis on MR images.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596750     DOI: 10.1007/s11060-010-0292-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.

Authors:  Dehe Kong; Eun Jung Park; Andrew G Stephen; Maura Calvani; John H Cardellina; Anne Monks; Robert J Fisher; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Genetic evidence for a tumor suppressor role of HIF-2alpha.

Authors:  Till Acker; Antonio Diez-Juan; Julian Aragones; Marc Tjwa; Koen Brusselmans; Lieve Moons; Dai Fukumura; Maria Paz Moreno-Murciano; Jean-Marc Herbert; Angelika Burger; Johanna Riedel; Gerd Elvert; Ingo Flamme; Patrick H Maxwell; Désiré Collen; Mieke Dewerchin; Rakesh K Jain; Karl H Plate; Peter Carmeliet
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

Review 4.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

Authors:  G L Semenza
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

5.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

6.  The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Authors:  John M Heddleston; Zhizhong Li; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

7.  Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

Authors:  Jeannette R Flynn; Libo Wang; David L Gillespie; Gregory J Stoddard; Jason K Reid; Jason Owens; Grant B Ellsworth; Karen L Salzman; Anita Y Kinney; Randy L Jensen
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

8.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

9.  Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.

Authors:  S Takano; K Tsuboi; Y Tomono; Y Mitsui; T Nose
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

10.  Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomas.

Authors:  Carlos A Scrideli; Carlos G Carlotti; Juliana F Mata; Luciano Neder; Helio R Machado; Sueli M Oba-Sinjo; Sergio Rosemberg; Suely K N Marie; Luiz G Tone
Journal:  J Neurooncol       Date:  2007-02-07       Impact factor: 4.506

View more
  18 in total

1.  Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.

Authors:  K Tateishi; U Tateishi; M Sato; S Yamanaka; H Kanno; H Murata; T Inoue; N Kawahara
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

2.  Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.

Authors:  Nobuyuki Kawai; Wei Lin; Wei-Dong Cao; Daisuke Ogawa; Keisuke Miyake; Reiji Haba; Yukito Maeda; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-30       Impact factor: 9.236

3.  Microfoci of malignant progression in diffuse low-grade gliomas: towards the creation of an intermediate grade in glioma classification?

Authors:  Zoé Pedeutour-Braccini; Fanny Burel-Vandenbos; Catherine Gozé; Coralie Roger; Audrey Bazin; Valérie Costes-Martineau; Hugues Duffau; Valérie Rigau
Journal:  Virchows Arch       Date:  2015-01-21       Impact factor: 4.064

4.  3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas.

Authors:  Q Zeng; B Jiang; F Shi; C Ling; F Dong; J Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

5.  Clinical and prognostic significance of HIF-1α in glioma patients: a meta-analysis.

Authors:  Qi Liu; Peicheng Cao
Journal:  Int J Clin Exp Med       Date:  2015-12-15

6.  Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.

Authors:  Panagiotis J Vlachostergios; Eleana Hatzidaki; Christina D Befani; Panagiotis Liakos; Christos N Papandreou
Journal:  Invest New Drugs       Date:  2013-05-05       Impact factor: 3.850

7.  The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.

Authors:  Pamela H S Tan; Su Shin Chia; Siew Lok Toh; James C H Goh; Saminathan Suresh Nathan
Journal:  Tissue Eng Part A       Date:  2014-04-30       Impact factor: 3.845

8.  Three-dimensional pulsed continuous arterial spin labeling and intravoxel incoherent motion imaging of nasopharyngeal carcinoma: correlations with Ki-67 proliferation status.

Authors:  Wenxiu Wu; Guihua Jiang; Zhifeng Xu; Ruoning Wang; Aizhen Pan; Mingyong Gao; Tian Yu; Linwen Huang; Qiang Quan; Jin Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

9.  Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.

Authors:  Arnulf Mayer; Fabienne Schneider; Peter Vaupel; Clemens Sommer; Heinz Schmidberger
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

10.  Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Authors:  Elodie A Pérès; Aurélie N Gérault; Samuel Valable; Simon Roussel; Jérôme Toutain; Didier Divoux; Jean-Sébastien Guillamo; Marc Sanson; Myriam Bernaudin; Edwige Petit
Journal:  Oncotarget       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.